M.L. Rutllant
M.L. Rutllant publishes mostly in Hematology, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Atrial Fibrillation Management and Outcomes, Hematopoietic Stem Cell Transplantation and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #6,262,325 of 7,710,434 ranked researchers
- Rank in Spain
- #152,591 of 204,306
- Works
- 16
- Citations
- 182
- Citations per work
- 11.4
What does M.L. Rutllant research?
M.L. Rutllant's work is mostly in Medicine (63%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1063.3%
- Medicine1063.3%
- Everything else636.7%
- 1Hematology21% of their works
- 2Cardiology and Cardiovascular Medicine16% of their works
- 3Surgery8% of their works
- 4Genetics8% of their works
- 5Emergency Medicine5% of their works
- 6Endocrinology, Diabetes and Metabolism5% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Hematopoietic Stem Cell Transplantation
- Antiplatelet Therapy and Cardiovascular Diseases
- Hematological disorders and diagnostics
- Hemoglobinopathies and Related Disorders
- Blood Coagulation and Thrombosis Mechanisms
- Venous Thromboembolism Diagnosis and Management
- Neutropenia and Cancer Infections
Which keywords describe M.L. Rutllant's research?
The keywords of their largest research topics: Antithrombotic Therapy, Inflammation, Prophylaxis, Anticoagulant Therapy, Atrial Fibrillation, Bone Marrow Niche, Hematopoietic Stem Cells and Antimicrobial Agents.
- Thrombin
- Sickle-cell Disease
- Protease-Activated Receptors
- FDG PET/CT
- Bone Marrow Biopsy
- Antimicrobial Agents
- Bone Marrow Niche
- Anticoagulant Therapy
- Inflammation
- Antithrombotic Therapy
- Prophylaxis
- Atrial Fibrillation
- Hematopoietic Stem Cells
- Aspirin
- Clopidogrel
- Febrile Neutropenia
- Pulmonary Embolism
- Thalassemia
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Antithrombotic Therapy42 topics
- Inflammation42 topics
- Prophylaxis42 topics
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Bone Marrow Niche31 topic
- Hematopoietic Stem Cells31 topic
- Antimicrobial Agents21 topic
- Aspirin21 topic
- Bone Marrow Biopsy21 topic
- Clopidogrel21 topic
- FDG PET/CT21 topic
- Febrile Neutropenia21 topic
- Protease-Activated Receptors21 topic
- Pulmonary Embolism21 topic
- Sickle-cell Disease21 topic
- Thalassemia21 topic
- Thrombin21 topic
- Venous Thromboembolism21 topic
Where does M.L. Rutllant work?
M.L. Rutllant's main affiliation in the publication record is Hospital de Sant Pau, Spain.
How many publications and citations does M.L. Rutllant have?
OpenAlex counts 16 works and 182 citations for M.L. Rutllant, an h-index of 5, ranking #6,262,325 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about M.L. Rutllant. Posts are plain text and can be reported.